Skip to content

Annogen B.V.

Annogen B.V.

At Annogen, we use our SuRE™ technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression. Also, we establish databases in which we functionally annotate millions of non-coding sequence variants for their effect on promoter and enhancer activity. This enables researchers to qualitatively interpret non-coding sequence variants in humans, animals and plants in the way we already can for coding sequence variants.

 

Expertise:

  • Promoter screens for gene and cell therapy, including inducible promoters
  • Functional annotation of non-coding sequence variants
  • Synthetic biology
  • Saturating mutagenesis screens
  • SafeHarbor screens for the identification of favorable genomic integrations sites
Annogen B.V.
Contactpersoon
Joris van Arensbergen, PhD
Adres
Science Park 406, 1098 XH Amsterdam
Telefoonnummer

At Annogen, we use our SuRE™ technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression. Also, we establish databases in which we functionally annotate millions of non-coding sequence variants for their effect on promoter and enhancer activity. This enables researchers to qualitatively interpret non-coding sequence variants in humans, animals and plants in the way we already can for coding sequence variants.

 

Expertise:

  • Promoter screens for gene and cell therapy, including inducible promoters
  • Functional annotation of non-coding sequence variants
  • Synthetic biology
  • Saturating mutagenesis screens
  • SafeHarbor screens for the identification of favorable genomic integrations sites
Contactpersoon
Joris van Arensbergen, PhD
Adres
Science Park 406, 1098 XH Amsterdam